Personalised cancer vaccine ‘activates immune system’ in early trials

Personalised vaccines have shown ‘promising signs’ in early clinical trials of patients with advanced cancers. Researchers have found the experimental treatment was “well tolerated” and the participants experienced “low-to-moderate” side effects. The findings from the phase one clinical trial were designed to boost the body’s natural defenses to fight cancer.
Read more at BBC Science Focus Magazine…

%d bloggers like this: